Trial Pains Secondary to Placebo Effect?
An interesting report has just been published showing that Naloxegol is beneficial in OIC [i]. Naloxegol is a µ opioid receptor (MOR) antagonist which – by virtue of pegylation – acts peripherally and not centrally. Hence, the analgesic effects of opioid therapy are unaffected while the very bothersome side effect Continue reading Trial Pains Secondary to Placebo Effect?